Don O’Sullivan

Don O'Sullivan is currently the Chief Business Officer at Asher Biotherapeutics since January 2022. Prior to this, Don held various roles at Genentech, including Vice President, Global Head of Oncology Partnering, Global Head of Immunology & Infectious Disease Partnering, Associate Director, Senior Manager, and Intern in business development. Don also worked at Genzyme as an Associate Director in Corporate Development. Don's educational background includes an MBA in Healthcare & Finance from The Wharton School, a PhD in Molecular Biology from the University of Cambridge, and a BSc in Biochemistry from Imperial College London.